By Hidden Values Daily Michael Yee, global head of biotech research at UBS, joins CNBC’s ‘Squawk on the Street’ to explain why he is bullish on biopharma stocks this year, the pharma M&A outlook, and more.
Source: https://www.youtube.com/watch?v=3PnmzsrmQdk
Pharma stocks are set to take off this year, says UBS’ Michael Yee
